The Capital Markets Tribunal has declined to allow Carbacid and Aksaya Investments to participate in a case seeking the termination of its takeover of BOC Kenya, saying issues raised on the buyout will be articulated by sector regulator.
The tribunal said although the two firms argued that any decision will ultimately affect them, the primary impact is on the Capital Markets Authority (CMA) because it is the regulator’s action that is being challenged.
